Ernexa Therapeutics Inc. Income Taxes Paid
Ernexa Therapeutics Inc. (ERNA) reported Income Taxes Paid of $68.00 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2015-11-09
- Ernexa Therapeutics Inc. income taxes paid for the quarter ending 2015-09-30 was $13.00K, a 333.33% increase year-over-year.
- Ernexa Therapeutics Inc. income taxes paid for the quarter ending 2015-06-30 was $28.00K, a 154.55% increase year-over-year.
- Ernexa Therapeutics Inc. income taxes paid for the quarter ending 2015-03-31 was $27.00K, a 50.00% increase year-over-year.
- Ernexa Therapeutics Inc. income taxes paid for the quarter ending 2014-12-31 was $3.00K.
- Ernexa Therapeutics Inc. income taxes paid for fiscal 2014 was $35.00K, a 34.62% increase from fiscal 2013.
- Ernexa Therapeutics Inc. income taxes paid for fiscal 2013 was $26.00K, a 42.22% decline from fiscal 2012.
- Ernexa Therapeutics Inc. income taxes paid for fiscal 2012 was $45.00K, a 21.05% decline from fiscal 2011.
- Ernexa Therapeutics Inc. income taxes paid for fiscal 2011 was $57.00K, a 14.00% increase from fiscal 2010.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2015-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $41.00K derived: sum of 2 quarters · filed 2015-11-09 | $68.00K 10-Q · filed 2015-11-09 | $71.00K derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $55.00K 10-Q · filed 2015-08-10 | $58.00K derived: sum of 3 quarters · filed 2015-08-10 | $61.00K derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | $27.00K 10-Q · filed 2015-05-08 | $30.00K derived: sum of 2 quarters · filed 2015-05-08 | $33.00K derived: sum of 3 quarters · filed 2015-11-09 | $44.00K derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $6.00K derived: sum of 2 quarters · filed 2015-11-09 | $17.00K derived: sum of 3 quarters · filed 2015-11-09 | $35.00K 10-K · filed 2015-03-27 |
| 2014-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $14.00K derived: sum of 2 quarters · filed 2015-11-09 | $32.00K 10-Q · filed 2015-11-09 | $32.00K derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $29.00K 10-Q · filed 2015-08-10 | $29.00K derived: sum of 3 quarters · filed 2015-08-10 | $32.00K derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $18.00K 10-Q · filed 2015-05-08 | $18.00K derived: sum of 2 quarters · filed 2015-05-08 | $21.00K derived: sum of 3 quarters · filed 2015-05-08 | $37.00K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $3.00K derived: sum of 2 quarters · filed 2015-03-27 | $19.00K derived: sum of 3 quarters · filed 2015-03-27 | $26.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $19.00K derived: sum of 2 quarters · filed 2014-11-07 | $26.00K 10-Q · filed 2014-11-07 | $26.00K derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $23.00K 10-Q · filed 2014-08-14 | $23.00K derived: sum of 3 quarters · filed 2014-08-14 | $25.00K derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $7.00K 10-Q · filed 2014-05-15 | $7.00K derived: sum of 2 quarters · filed 2014-05-15 | $9.00K derived: sum of 3 quarters · filed 2014-05-15 | $42.00K derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.00K derived: sum of 2 quarters · filed 2014-03-31 | $35.00K derived: sum of 3 quarters · filed 2014-03-31 | $45.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $35.00K derived: sum of 2 quarters · filed 2013-11-14 | $45.00K 10-Q · filed 2013-11-14 | $47.00K derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $43.00K 10-Q · filed 2013-08-14 | $45.00K derived: sum of 3 quarters · filed 2013-08-14 | $75.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $10.00K 10-Q · filed 2013-05-13 | $12.00K derived: sum of 2 quarters · filed 2013-05-13 | $42.00K derived: sum of 3 quarters · filed 2013-05-13 | $49.00K derived: sum of 4 quarters · filed 2013-05-13 |
| 2011-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $32.00K derived: sum of 2 quarters · filed 2013-03-29 | $39.00K derived: sum of 3 quarters · filed 2013-03-29 | $57.00K 10-K · filed 2013-03-29 |
| 2011-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $37.00K derived: sum of 2 quarters · filed 2012-11-09 | $55.00K 10-Q · filed 2012-11-09 | $55.00K derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $25.00K 10-Q · filed 2012-08-14 | $25.00K derived: sum of 3 quarters · filed 2012-08-14 | $57.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $18.00K 10-Q · filed 2012-05-11 | $18.00K derived: sum of 2 quarters · filed 2012-05-11 | $50.00K derived: sum of 3 quarters · filed 2012-05-11 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $32.00K derived: sum of 2 quarters · filed 2012-03-30 | $50.00K 10-K · filed 2012-03-30 | |
| 2010-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $50.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $18.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |